Chun Wai Mai | Cancer | Best Researcher Award

Prof. Dr. Chun Wai Mai | Cancer | Best Researcher Award

Professor, IMU University, Malaysia 🌟

Dr. Chun-Wai Mai, a highly accomplished researcher and professor from Malaysia, is devoted to understanding the mechanisms behind tumorigenesis and metastasis. With a vision to uncover the origins of cancer, Dr. Mai aims to enhance clinical prognosis and improve patient outcomes. Over the years, he has held pivotal academic and research roles, contributing significantly to oncology, stem cell biology, genomics, and drug discovery. His work embodies a commitment to advancing medical science and tackling cancer at its roots.

Profile

Orcid

Education 🎓

Dr. Chun-Wai Mai earned his PhD in Pharmaceutical Sciences (2010–2014) and Bachelor of Pharmacy degree (2005–2009) from the International Medical University (IMU) in Kuala Lumpur, Malaysia. His strong academic foundation has fueled his impactful contributions to cancer research and drug development.

Experience 🧑‍🔬

Dr. Mai is currently a Professor at the Centre for Cancer and Stem Cell Research, International Medical University. He previously served as an Associate Professor at UCSI University (2022–2025), a Postdoctoral Fellow at Shanghai Jiao Tong University School of Medicine (2020–2022), and as a Senior Lecturer (2018–2020) and Lecturer (2010–2018) at IMU. His extensive academic journey reflects his dedication to education and research excellence.

Research Interests 🔬

Dr. Mai’s research focuses on tumorigenesis, metastasis, stem cells, and drug discovery, with a keen interest in genomics and anticancer mechanisms. He is driven by the goal of developing targeted therapies to combat cancer and improve patient outcomes, particularly in addressing the challenges of drug resistance and cancer progression.

Awards 🏆

Dr. Mai is a distinguished member of esteemed organizations, including the European Association for Cancer Research and the Royal Society of Chemistry. His groundbreaking research has earned recognition in oncology and stem cell therapy, marking him as a leader in his field.

Publications 📚

Phytochemical Analysis and Biological Activities of Flavonoids and Anthraquinones from Cassia alata (Linnaeus) Roxburgh (Plants, 2025): 10.3390/plants14030362

Scoping Review of Enablers and Challenges of Implementing Pharmacogenomics Testing in Primary Care Settings (BMJ Open, 2024): 10.1136/bmjopen-2024-087064

Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities (Sci, 2024): 10.3390/sci6040068

Revolutionizing Treatment for Nasopharyngeal Cancer with Stem Cell and Genetically Engineered Therapies (Frontiers in Immunology, 2024): 10.3389/fimmu.2024.1484535

Molecular Mechanism of Tocotrienol-Mediated Anticancer Properties: Systematic Review (Nutrients, 2023): 10.3390/nu15081854

Conclusion

Dr. Chun-Wai Mai’s outstanding academic background, impactful research contributions, and leadership in oncology and drug discovery make him an excellent candidate for the Best Researcher Award. His focus on advancing cancer therapies aligns with the award’s vision of recognizing transformative scientific contributions. By further showcasing patents, grants, and global collaborations, Dr. Mai’s profile could achieve even greater prominence in the scientific community.

Krzysztof Jeziorski | Oncology | Best Researcher Award

Dr Krzysztof Jeziorski | Oncology | Best Researcher Award

Dr, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland  🌟

Assoc. Prof. Dr. Krzysztof Grzegorz Jeziorski, MD, PhD, is a distinguished physician specializing in oncology with a rich career spanning over three decades. He currently serves as an Associate Professor at the Maria Skłodowska-Curie Memorial Cancer Center in Warsaw, Poland, and as a Clinical Trials Consultant at the National Institute of Geriatrics. Dr. Jeziorski has held prestigious roles, including Dean of the Faculty of Health Sciences, and is renowned for his expertise in gastrointestinal oncology and clinical research.

Profile

Orcid

Education 🎓

Dr. Jeziorski’s academic journey is rooted in excellence. He earned his medical degree from the Medical University of Warsaw in 1983, followed by advanced specialties in general medicine, chemotherapy, and clinical oncology at the Medical Center of Postgraduate Education. He achieved his Doctorate in Medical Sciences in 1992 and received his Habilitation degree in 2009 from the Maria Skłodowska-Curie Cancer Center.

Professional Experience 💼

With extensive experience in oncology and academia, Dr. Jeziorski has been an Associate Professor at the Cancer Center since 1988. He has also served as Dean of the Faculty of Health Sciences and held academic positions at the Polish Academy of Sciences. His clinical expertise is complemented by his leadership in over 20 international trials as Principal Investigator.

Research Interests 🔬

Dr. Jeziorski focuses on gastrointestinal tract oncology, aiming to advance therapeutic approaches for neoplasms. His dedication to clinical research has significantly contributed to international studies addressing GI cancers.

Awards 🏆

Throughout his illustrious career, Dr. Jeziorski has received numerous distinctions, including recognition for his specialty training in cancer chemotherapy and contributions to healthcare management and oncology research.

Publications Top Notes 📚

Artificial Intelligence in Oncology
Published: 2024DOI: 10.3390/app15010269

Lost in Communication: Do Family Physicians Provide Patients with Information on Preventing Diet-Related Diseases?
Published: 2022DOI: 10.3390/ijerph191710990

Hyperthermia in Rheumatic Diseases: A Promising Approach?
Published: 2018DOI: 10.5114/reum.2018.79503

HER2 Status in Advanced Gastric Cancer
Published: 2017DOI: 10.1158/1535-7163.MCT-15-0887

Preservation of Duodenal Passage and Quality of Life Post-Gastrectomy
Published: 2017DOI: 10.23736/S0026-4733.17.07364-3

Rheumatic and Oncological Diseases: Common Challenges
Published: 2017DOI: 10.5114/reum.2017.68908

Conclusion

Dr. Jeziorski’s distinguished career in oncology, extensive clinical research experience, and academic contributions make him a strong candidate for the Best Researcher Award. His expertise in gastrointestinal cancer and dedication to advancing treatment protocols align well with the award’s objectives. Addressing areas of improvement could elevate his profile further, but his current achievements are highly commendable.